Tris Pharma
David Brennan CPA, MBA, is a seasoned finance professional with extensive experience in various leadership roles across the pharmaceutical and healthcare sectors. Currently serving as Controller at Tris Pharma since April 2021, David previously held the position of Corporate Controller at Pharmaceutical Associates Inc. from November 2019 to April 2021, where responsibilities included managing general accounting and financial reporting. David's career highlights include directing finance functions at Accord Healthcare, leading financial accounting practices at Ranbaxy, and overseeing global revenue at Celgene. With a robust educational background including an MBA in International Management from Thunderbird School of Global Management and a BS in Accounting from Alfred University, David has consistently demonstrated expertise in financial strategy and performance analysis throughout a diverse career.
This person is not in any teams
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.